Cva Family Office, LLC Acadia Pharmaceuticals Inc Transaction History
Cva Family Office, LLC
- $619 Million
- Q4 2024
A detailed history of Cva Family Office, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Cva Family Office, LLC holds 50 shares of ACAD stock, worth $890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$890% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
280Shares Held
158MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$764 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$247 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$244 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$215 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$106 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.88B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...